Same-store growth is one of the hottest topics in dentistry right now. Most practices are measuring the wrong half of it.
Private practices are talking about it. Groups are talking about it. DSOs are talking about it. Everyone wants to know how to increase production without adding locations, how to grow revenue without growing overhead, and how to get more out of the patients already walking through the door.
After nearly two decades looking at practice performance, treatment acceptance, patient flow, staffing models, and organizational design, one pattern keeps showing up. Practices spend a tremendous amount of time measuring outcomes. Very few spend enough time measuring the things that create those outcomes.
Take financing. The same line comes up constantly in these conversations: “our patients don’t need financing,” “our patients don’t use financing,” “our patients pay cash.” Maybe. But that is not the metric worth tracking.
The Questions Most Practices Aren’t Asking
If same-store growth is the real objective, the relevant questions look different from the ones most practices are asking:
- How many patients were presented financing options?
- How many applications were submitted, and how many were approved?
- How many approved patients moved forward with treatment, and how many didn’t?
- How many unscheduled treatment plans existed at the end of the month?
- How many patients with diagnosed treatment walked out without a clear path forward?
Those are growth metrics. Most practices never look at them. Instead, the focus stays on production after the fact, collections after the fact, revenue after the fact. The scoreboard, not the plays that create the score.
|
Industry-wide, roughly 56% of treatment plans presented get scheduled, but only 46% are actually completed — a gap that compounds across every chair, every month. CERTIFY Health, Dental Market Study, 2025 |
Where the Game Is Actually Won
Using a football analogy: most organizations are obsessed with the end zones. The front office, the back office, insurance, collections, scheduling, claims, payroll. All important. None of it is where the game is won.
The game is won at midfield. The space between diagnosis and decision. The space between treatment presentation and treatment acceptance. The space between “I need this treatment” and “I’m ready to move forward.” That is where trust lives, where financing becomes relevant, and where patients decide whether they are moving forward, postponing care, or disappearing entirely.
|
Across general dentistry, treatment acceptance rates typically range from 50–60%, with elective and high-ticket procedures — the cases with the most revenue at stake — converting at the lowest rates. Dentx, Dental Case Acceptance Benchmarks, 2025–2026 |
Why Cash-Paying Patients Are Choosing Financing Anyway
Consumer behavior has shifted. In 2026, financing is no longer reserved for patients who cannot afford treatment. A meaningful share of consumers who could pay cash choose not to, because preserving liquidity matters, managing cash flow matters, and keeping capital available for other priorities matters. Interest-free and low-friction financing options have become a normal part of consumer decision-making across income levels, not just at the lower end.
|
57% of consumers who use point-of-sale financing say the primary reason is cash flow management — not an inability to pay. Affordability is only part of the story. Empower / Motley Fool Money, Buy Now, Pay Later Trends Report, 2025 |
Patients with available healthcare credit tend to move through the treatment acceptance process differently than those without it. They say yes more often. They schedule more often. They move forward more often. Yet many practices aren’t tracking financing utilization, financing approvals, or how approved patients convert relative to non-approved patients. They are not tracking how many treatment plans die before financing is ever discussed.
What the Strongest Practices Are Measuring
The practices seeing the strongest same-store growth are not simply measuring production. They are measuring patient movement. They are measuring trust. They are measuring treatment acceptance, financing utilization, and the activities happening at midfield, before the patient ever says no.
The scoreboard only tells you what happened. Midfield tells you why. If same-store growth is genuinely the objective, understanding what helps patients move forward should be one of the most important conversations in the practice, not after the patient declines, but before.
|
ZIA helps practices build the staffing and operational structure to track treatment acceptance and financing conversion at the point where it actually matters. |
Disclaimer: ZIA is not compensated by CareCredit or any financing provider. Any financing companies referenced are used solely as examples commonly recognized within dentistry.